Expertise in
4
conditions

Sulaiman Nanji

76 Stuart St, 
Kingston, ON, CA 
Expertise in
4
conditions
76 Stuart St, 
Kingston, ON, CA 

Overview

Sulaiman Nanji practices practicing medicine in Kingston, Canada.

Mr. Nanji is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Liver Cancer, Lung Metastases, Gallbladder Removal, and Hepatectomy.

He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

76 Stuart St, Kingston, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial: Tranexamic Acid (TXA) Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection: A Randomized Controlled Trial
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial: Tranexamic Acid (TXA) Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection: A Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Single-arm Phase II Trial of Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
A Single-arm Phase II Trial of Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Device
Study Phase: Phase 2
View 1 Less Clinical Trial

70 Total Publications

Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B- and Hepatitis C-Infected Patients in Rwanda.
Assessing Adherence to Hepatocellular Carcinoma Surveillance Guidelines in Hepatitis B- and Hepatitis C-Infected Patients in Rwanda.
Journal: JCO global oncology
Published: March 06, 2026

Frequently Asked Questions about Sulaiman Nanji

Is Sulaiman Nanji a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sulaiman Nanji is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sulaiman Nanji participate in research or clinical trials?

Yes. Sulaiman Nanji has published 70 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Sulaiman Nanji's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nanji's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile